DGX vs IQV
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
DGX · Quest Diagnostics$255.63 ▲ 0.35%
IQV · IQVIA Holdings$271.83 ▲ 2.62%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- DGX +40.5%
- IQV +27.6%
Head to head
| Metric | DGX | IQV |
|---|---|---|
| Price | $255.63 | $271.83 |
| Change today | ▲ 0.35% | ▲ 2.62% |
| Market cap | $28.12B | $44.80B |
| Return, 3 months | +7.6% | +12.3% |
| Return, year to date | +49.2% | +20.6% |
| Return, 1 year | +44.3% | +29.2% |
| P/E (TTM) | 25.5 | 33.1 |
| P/B | 3.7 | 6.7 |
| P/E percentile vs own 5y | 99th | 53rd |
| Dividend yield | 1.32% | – |
| Revenue growth (YoY, latest qtr) | +10.0% | +8.0% |
| Net profit growth (YoY) | +25.9% | +6.0% |
| Gross margin | 33.1% | 33.1% |
| Operating margin | 14.6% | 13.8% |
| Net margin | 9.5% | 8.1% |
| Return on equity | 15.1% | 21.7% |
| Analyst target vs. price | +1.5% | +15.4% |
| Analyst buy share | 43% | 86% |
| RSI (14) | 67 | 54 |
| 30-day volatility | 21.8% | 29.0% |
| Max drawdown, 1 year | -11.6% | -35.9% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- IQV is the largest of the group by market value.
- DGX has returned the most over the past year.
- DGX carries the lowest trailing P/E.
- DGX is growing revenue fastest.
- DGX keeps the most profit per dollar of sales.
- DGX has been the calmest stock over the last 30 days.